Clinical Trial Update: RENEW-AI: Personalizing Scleroderma Management With an AI Health Coach [NA]

View source ↗

Summary

This update reports the completion of the RENEW-AI trial evaluating an AI health coach to personalize management of systemic sclerosis (scleroderma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Snippet

Sponsor: University of Michigan | Conditions: Scleroderma | NA | Status: COMPLETED